Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Putter

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.
Leukemia|June 11, 2010
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantationA C Lankester, M B Bierings, E R van Wering, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 22, 2018
Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trialY H M Claassen, H H Hartgrink, W O de Steur, et al.
Lancet (London, England)|March 9, 2010
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialR A Nout, V T H B M Smit, H Putter, et al.
ESMO Open|March 5, 2023
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trialE A Dijkstra, W H Zwart, P J Nilsson, et al.
BJS Open|October 9, 2019
Cluster-randomized crossover trial of chlorhexidine-alcohol <i>versus</i> iodine-alcohol for prevention of surgical-site infection (SKINFECT trial)A Charehbili, M B G Koek, J C A de Mol van Otterloo, et al.
The British Journal of Surgery|April 14, 2018
Association between hospital volume and quality of gastric cancer surgery in the CRITICS trialY H M Claassen, J W van Sandick, H H Hartgrink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2018
Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trialY H M Claassen, H H Hartgrink, J L Dikken, et al.
Trials|March 14, 2025
Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple resection (SPARROW): a study protocol for a multicentre, open-label, randomised controlled trialD H M Droogh, M G J de Boer, J van Prehn, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.
Leukemia|June 11, 2010
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantationA C Lankester, M B Bierings, E R van Wering, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 22, 2018
Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trialY H M Claassen, H H Hartgrink, W O de Steur, et al.
Lancet (London, England)|March 9, 2010
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialR A Nout, V T H B M Smit, H Putter, et al.
ESMO Open|March 5, 2023
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trialE A Dijkstra, W H Zwart, P J Nilsson, et al.
BJS Open|October 9, 2019
Cluster-randomized crossover trial of chlorhexidine-alcohol <i>versus</i> iodine-alcohol for prevention of surgical-site infection (SKINFECT trial)A Charehbili, M B G Koek, J C A de Mol van Otterloo, et al.
The British Journal of Surgery|April 14, 2018
Association between hospital volume and quality of gastric cancer surgery in the CRITICS trialY H M Claassen, J W van Sandick, H H Hartgrink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2018
Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trialY H M Claassen, H H Hartgrink, J L Dikken, et al.
Trials|March 14, 2025
Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple resection (SPARROW): a study protocol for a multicentre, open-label, randomised controlled trialD H M Droogh, M G J de Boer, J van Prehn, et al.
Pageof 16